Finance
Wellness Network includes videos that touch on 24 therapeutic areas.
The Premier Partner Program is set to launch for benefits plans starting in January 2022.
The company plans to use the new funds for global expansion and product development.
The startup aims to be operating in more than seven countries by the end of 2021.
HIMSS21
Reenita Das, partner and SVP for healthcare and life sciences at Frost and Sullivan, said that femtech companies only accounted for 1.8% of total digital health investments in 2020.
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Once combined, the company will operate as HeartFlow Group and trade on the NYSE under symbol HFLO.
The proceeds will be used to fund the clinical development of MyopiaX, the company's lead product in childhood myopia.
The Israeli company now has a total of $9 million in venture funding.
This brings the company's total raise to $140 million.